Alpha Cancer Technologies secured private round of financing
CannaCure Corporation closed financing with Canadian and US investors.
MaRS Health and University of Toronto Health Innovation Hub (H2i) supported ImmunoBiochem secured new financing
Cannatest Photonics completed private placement
SIG.NUM closed financing with Anges Québec members and Anges Québec Capital.
AmorChem II Fund initial closed at $44.2M with commitments from Investissement Québec, Fonds de solidarité, Merck and others
LightIntegra Technology, the maker of ThromboLUX, closed $3.5M private round of financing
HBM Healthcare Investments backed Vitaeris entered into collaboration and purchase option agreement with CSL Limited
Resverlogix closed financing with Shenzhen Hepalink Pharmaceutical of 60,416,667 equity units at $1.44 per unit for $87 million.
Qvella raised US $20M in Series B from RA Capital, Whitecap Venture Partners, Hatteras Ventures, Sands Capital, bioMérieux
Prometic Life Sciences closed US $80M or CDN $100M line of credit financing with Structured Alpha LP, an affiliate of Peter J. Thomson's Thomvest Asset Management
Akumin closed IPO by way of qualifying common shares issuable upon the exercise of previously issued or converted special warrants and broker warrants.